The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride
- 1 February 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 40 (2) , 142-143
- https://doi.org/10.1111/j.2042-7158.1988.tb05202.x
Abstract
Cisplatin administered by either the intravenous (i.v.) or intra-cerebroventricular (i.c.v.) route produced emesis in cats. The average time to onset of emesis was decreased significantly (4.0 min versus 100.6 min) when cisplatin was administered i.c.v. Zacopride administered either i.c.v. (0.02 mg) or i.v. (0.1 mg kg−1) completely blocked the emesis due to cisplatin given by either route. Their data show that cisplatin possesses a central emetic component and that this is blocked by zacopride.This publication has 4 references indexed in Scilit:
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motilityDigestive Diseases and Sciences, 1986
- CISPLATIN-INDUCED VOMITING ELIMINATED BY ABLATION OF THE AREA POSTREMA IN CATS1984